Tumor Spectrum, Tumor Latency and Tumor Incidence of the Pten-Deficient Mice
2007

Tumor Development in Pten-Deficient Mice

Sample size: 33 publication 10 minutes Evidence: high

Author Information

Author(s): Lu Tsai-Ling, Chang Junn-Liang, Liang Chih-Chia, You Li-Ru, Chen Chun-Ming

Primary Institution: National Yang-Ming University, Taipei, Taiwan

Hypothesis

The study aims to explore the genesis of Pten-deficient malignancies in multiple tissue lineages of the adult mouse.

Conclusion

The study found that various tissues are highly susceptible to tumorigenesis after the Pten gene is excised.

Supporting Evidence

  • The overall mean latency of Pten-deficient tumor formation was 17 weeks.
  • 76.9% of mutant females developed lymphomas compared to 40% of males.
  • Mutant males developed various cancers including prostate and intestinal cancer.

Takeaway

Mice without the Pten gene get tumors more easily, especially in certain organs like the prostate and endometrium.

Methodology

The study used an inducible Cre/loxP system to delete Pten exon 5 in the systemic organs of specific mouse models and monitored tumor development over time.

Potential Biases

Potential bias in tumor detection and monitoring due to the subjective nature of pathological analysis.

Limitations

The study may not fully represent human cancer due to differences in mouse models and genetic backgrounds.

Participant Demographics

The study involved 33 Pten-deficient mice (20 males and 13 females).

Statistical Information

P-Value

0.007

Statistical Significance

p=0.007

Digital Object Identifier (DOI)

10.1371/journal.pone.0001237

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication